Latka logo

MaganaMed GmbH vs Qchain: Revenue, Funding & Team Size Compared

MaganaMed GmbH generates $330K in revenue; Qchain generates $330K. MaganaMed GmbH and Qchain are close to the same size by revenue. The table below compares MaganaMed GmbH and Qchain on funding, valuation, customers, team size and headquarters — every figure GetLatka has verified for each company.

MaganaMed GmbH vs Qchain compared on revenue, funding, valuation, customers and team size
CompanyMaganaMed GmbH logoMaganaMed GmbHThis companyQchain logoQchain
Revenue$330K$330K
Team size33
Founded20172017
HQUnited StatesDoha, Qatar

Want the full dataset? GetLatka tracks revenue, funding and team history for thousands of SaaS companies, with charts, growth rates and founder interviews.

MaganaMed GmbH logo

MaganaMed GmbH at a glance

MaganaMed GmbH generates $330K in revenue with 3 employees, headquartered in United States.

Revenue
$330K
Team size
3
Founded
2017

Intuitive and secure software for clinical trials: from electronic data capture (EDC) with eCRFs (electronic case report forms) to ePRO/eCOA/eDiary. Compliant with GCP, FDA CFR part 11, GDPR (german: DSGVO), ISO 14155. Meets all…

Qchain logo

Qchain at a glance

Qchain generates $330K in revenue with 3 employees, headquartered in Doha, Qatar.

Revenue
$330K
Team size
3
Founded
2017

QChain is an award-winning blockchain technology startup based in Qatar, building novel solutions in compliance and cybersecurity.

Other MaganaMed GmbH alternatives

MaganaMed GmbH competes with more than the companies on this page. Browse the full alternative lists to compare revenue, funding and team size across the category.

MaganaMed GmbH vs Qchain: frequently asked questions

Is MaganaMed GmbH or Qchain bigger?

MaganaMed GmbH is the bigger company by revenue, at $330K against $330K for Qchain.

How much revenue does MaganaMed GmbH make?

MaganaMed GmbH generates $330K in annual revenue with a team of 3.

How much revenue does Qchain make?

Qchain generates $330K in annual revenue with a team of 3.